Posted by Site Administrator on March 20, 2013
MDA has awarded a $400,000 grant to National Institutes of Health (NIH) Laboratory of Neurogenetics researchers to perform exome sequencing on samples taken from 1,000 people with sporadic amyotrophic lateral sclerosis (ALS). The project will be led by neurologist Bryan Traynor, head of the Neuromuscular Diseases Research Group at the NIH in Bethesda, Md.
Categories: ALS News, Research News, Technology, Treatments, Uncategorized
| 
Tags: ALS, ALS community, ALS diagnosis, ALS diagnostics, ALS research, ALS treatments, amyotrophic lateral sclerosis, Bob Stehlin, Coriell ALS Repository., DNA ALS, exome sequencing ALS, Lou Gehrig's disease, MDA translational research program, MDA Vice President of Research Jane Larkindale, Muscular Dystrophy Association MDA, National Institutes of Health (NIH), National Institutes of Health Laboratory of Neurogenetics, PALS, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, whole genome sequencing ALS
| 
No comments
Posted by Site Administrator on March 1, 2013
Because of the relentless effects of ALS, a diverse group of ALS voices — patients, families, organizations and the community — came together to speak about their experiences with ALS and to urge the FDA to work with them to overcome some of the obstacles faced in ALS research, clinical trials and standards of care.
Categories: Clinical Trials, Research News, Treatments
| Tags: a diverse group of ALS voices — patients, ALS, ALS clinical trials, ALS community, ALS cure, ALS medical care, ALS research, ALS research funding, ALS survivor Robert Anderson, ALS treatments, amyotrophic lateral sclerosis, Because of the relentless effects of ALS, Bob Stehlin, clinical trials and standards of care., Dr. Jonathan Glass, families, fast-track trials ALS, FDA, FDA ALS, Food and Drug Administration, Lou Gehrig's disease, MDA Senior Vice President of Advocacy Annie Kennedy, MDA/ALS Center of Hope in Philadelphia, MDA/ALS Clinic at Methodist Neurological Institute in Houston, Muscular Dystrophy Association MDA, organizations and the community — came together to speak about their experiences with ALS and to urge the FDA to work with them to overcome some of the obstacles faced in ALS research, PALS, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, Sara M. Feldman, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, Stan Appel, Steven M. Derks
| No comments
Posted by Site Administrator on January 7, 2012
A growing body of evidence suggests that malfunction of the immune system is at least part of the ALS disease process. Now scientists are testing whether mouse CTLA4-FC effectively blocks CD86
Categories: Research News
| Tags: abatacept, ALS, ALS community, ALS research, ALS Therapy Development Institute, amyotrophic lateral sclerosis, CD86, costimulatory pathway, CTLA4-FC, CTLA4-FC in mice, human fusion protein, Immunomodulator CTLA4-FC, Lou Gehrig's disease, MDA, Muscular Dystrophy Association, Muscular Dystrophy Association MDA, RASCALS, RASCALS Foundation, Robert A. Stehlin Campaign for ALS, SOD1 ALS mice, St.Louis RASCALS ALS Lou Gehrig's Disease amotrophic lateral sclerosis, targeting signaling protein
| No comments
